Simtuzumab (AB 0024, GS 6624) is a monoclonal antibody directed against Lysyl oxidase like-2 (LOXL2). Simtuzumab can be used for the research of primary sclerosing cholangitis (PSC)[1].
Molecular Weight:
(145.5 kDa)
Purity:
99
CAS Number:
[1318075-13-6]
Target:
Monoamine Oxidase
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted